These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Comprehensive Survey of CDK Inhibitor Selectivity in Live Cells with Energy Transfer Probes
preprintsubmitted on 18.12.2019, 23:48 and posted on 23.12.2019, 20:27 by Carrow Wells, Jim Vasta, Cesear R. Corona, Jennifer Wilkinson, Chad A. Zimprich, Morgan R. Ingold, Julie E. Pickett, David Drewry, Kathryn Maria Pugh, Kilian Huber, Mei Cong, Poncho Meisenheimer, Timothy M. Willson, Matthew B. Robers
A panel of cell-permeable energy transfer probes has been developed to quantify target occupancy for all 21 CDKs in live, intact cells. Here we present the first comprehensive evaluation of intracellular isozyme potency and selectivity for a collection of 46 clinically-advanced CDKi’s and tool molecules. Here we provide a broadly applicable method for evaluating the selectivity of chemical matter for CDKs in living cells, and present a refined set of tool molecules to study CDK function.
Illuminating Function of the Understudied Druggable Kinome
National Institute of Diabetes and Digestive and Kidney DiseasesFind out more...
A UK Hub to Catalyse Open Target Discovery.
Wellcome TrustFind out more...